Haystack MRD® receives New York State approval

Precision Medicine World Conference 2023 Silicon Valley

Haystack’s co-founder and Chief Innovation Officer, Josh Cohen, will be participating in a panel discussion at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valey, CA. The panel, “Liquid Biopsy for Minimal Residual Disease,” will take place on January 26 and will bring together recognized leaders in the MRD field. With over 2,500 attendees from around the world, PMWC is the foremost precision medicine conference, promoting collaboration and knowledge-sharing among top global researchers, medical professionals, and biotech. 

Josh Cohen, Co-founder and Chief Innovation Officer

PMWC panel discussion

Title: Liquid Biopsy for Minimal Residual Disease
Track: 4
Date: January 26, 2023
Time: 3:30pm – 4:15pm Pacific
Location: Santa Clara, CA

Subscribe for updates

No spam, notifications only about new products, updates.
News and events

Meet us at ESMO 2026

Visit the Quest Diagnostics booth #8002 | 23-27 October | Madrid, Spain
Join us at the 2026 European Society for Medical Oncology (ESMO) Congress as we share how Haystack MRD, the highly optimized evolution of the chemistry employed in

Follow us on social media

Complete the form for instant access

Download the whitepaper

Patient access application mailing instructions

Haystack MRD
C/O Quest Diagnostics
2501 S State Hwy 121, Suite 1100
Lewisville, TX 75067

Para solicitar ayuda financiera, complete la solicitud y firme la autocertificación.

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Visit Johns Hopkins School of Medicine to learn more.
Visit Johns Hopkins School of Medicine to learn more.
Visit Johns Hopkins School of Medicine to learn more.